Anti-HLA-E (Human) mAb (Clone: 4D12)
MBL Life Sciences
- Catalog No.:
- MBL-K0215-3
- Shipping:
- Calculated at Checkout
        
            
        
        
        $336.00
    
         
                            | Product Specifications | |
| Application | FC, IHC | 
| Reactivity | Human | 
| Clonality | Monoclonal IgG1 | 
| Host | Mouse | 
| Immunogen | Antibody obtained by immunizing HLA-B27 transgenic mice to HLA-E protein | 
| Formulation | 100 μg IgG in 100 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained. | 
| Storage | |
| Documents & Links for Anti-HLA-E (Human) mAb (Clone: 4D12) | |
| Datasheet | Anti-HLA-E (Human) mAb (Clone: 4D12) Datasheet | 
| Documents & Links for Anti-HLA-E (Human) mAb (Clone: 4D12) | |
| Datasheet | Anti-HLA-E (Human) mAb (Clone: 4D12) Datasheet | 
| Citations for Anti-HLA-E (Human) mAb (Clone: 4D12) – 3 Found | 
| Nguyen, S; Beziat, V; Dhedin, N; Kuentz, M; Vernant, J P; Debre, P; Vieillard, V. HLA-E upregulation on IFN-gamma-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT. Bone Marrow Transplantation. 2009;43(9):693-9.  PubMed - Comments: Used in: FCM | 
| Tsukamoto, Nobuo; Okada, Starlyn; Onami, Yoko; Sasaki, Yusuke; Umezawa, Kazuo; Kawakami, Yutaka. Impairment of plasmacytoid dendritic cells for IFN production by the ligand for immunoglobulin-like transcript 7 expressed on human cancer cells. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research. 2009;15(18):5733-43.  PubMed - Comments: Used in: FCM | 
| Cui, Chang-Hao; Miyoshi, Shunichiro; Tsuji, Hiroko; Makino, Hatsune; Kanzaki, Seiichi; Kami, Daisuke; Terai, Masanori; Suzuki, Harumi; Umezawa, Akihiro. Dystrophin conferral using human endothelium expressing HLA-E in the non-immunosuppressive murine model of Duchenne muscular dystrophy. Human Molecular Genetics. 2011;20(2):235-44.  PubMed - Comments: Used in: IHC | 
 
         
                             
                                        